Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

nork Roy, V., LaPlant, B. R., Gross, G. G., Bane, C. L., Palmieri, F. M.
Argitaratua 2009

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

nork Inwards, D. J., Fishkin, P. A., LaPlant, B. R., Drake, M. T., Kurtin, P. J., Nikcevich, D. A., Wender, D. B., Lair, B. S., Witzig, T. E.
Argitaratua izan da Ann Oncol (2014)

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

nork Inwards, D J, Fishkin, P A, LaPlant, B R, Drake, M T, Kurtin, P J, Nikcevich, D A, Wender, D B, Lair, B S, Witzig, T E
Argitaratua izan da Ann Oncol (2019)

Elevated Soluble IL-2Rα, IL-8, and MIP-1β Levels are Associated with Inferior Outcome and are Independent of MIPI Score in Patients with Mantle Cell Lymphoma

nork Sonbol, M. B., Maurer, M. J., Stenson, M. J., Allmer, C., LaPlant, B. R., Weiner, G. J., Macon, W. R., Cerhan, J. R., Witzig, T. E., Gupta, M.
Argitaratua izan da Am J Hematol (2014)

Validation of a vitamin D replacement strategy in vitamin D-insufficient patients with lymphoma or chronic lymphocytic leukemia

nork Sfeir, J G, Drake, M T, LaPlant, B R, Maurer, M J, Link, B K, Berndt, T J, Shanafelt, T D, Cerhan, J R, Habermann, T M, Feldman, A L, Witzig, T
Argitaratua izan da Blood Cancer J (2017)

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

nork Witzig, T E, Reeder, C B, LaPlant, B R, Gupta, M, Johnston, P B, Micallef, I N, Porrata, L F, Ansell, S M, Colgan, J P, Jacobsen, E D, Ghobrial, I M, Habermann, T M
Argitaratua 2011

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

nork Castellino, A., Chiappella, A., LaPlant, B. R., Pederson, L. D., Gaidano, G., Macon, W. R., Inghirami, G., Reeder, C. B., Tucci, A., King, R. L., Congiu, A., Foran, J. M., Pavone, V., Rivera, C. E., Spina, M., Ansell, S. M., Cavallo, F., Molinari, A. L., Ciccone, Giovannino, Habermann, T. M., Witzig, T. E., Vitolo, U., Nowakowski, G. S.
Argitaratua izan da Blood Cancer J (2018)